There is a high potential for kratom misuse in self-medicating for pain or anxiety, leading to significant health risks. Unregulated use can exacerbate these issues and lead to severe health complications. Schedule I classification will help prevent such misuse and protect public health. Effective regulation is essential for ensuring safety.

https://www.fda.gov/news-events/public-health-focus/fda-and-kratom